Implementing Regulation (EU) 2021/808 concerns, among others, performance criteria for analytical methods in relation to residues of pharmacologically active substances in feed. It should, however, be clarified that Implementing Regulation concerns only the methods used to verify compliance with certain rules fixing regulatory levels in feed, covered by the multi-annual national control plans in the area of residues of pharmacologically active substances mentioned in Commission Implementing Regulation (EU) 2022/1646 [Commission Implementing Regulation (EU) 2022/1646 of 23 September 2022 on uniform practical arrangements for the performance of official controls as regards the use of pharmacologically active substances authorised as veterinary medicinal products or as feed additives and of prohibited or unauthorised pharmacologically active substances and residues thereof, on specific content of multi-annual national control plans and specific arrangements for their preparation (OJ L 248, 26.9.2022, p. 32, ELI: http://data.europa.eu/eli/reg_impl/2022/1646/oj).], and does not concern the methods used to verify compliance with rules on cross-contamination of antimicrobial active substances in non-target feed, referred to in Commission Delegated Regulation (EU) 2024/1229 [Commission Delegated Regulation (EU) 2024/1229 of 20 February 2024 supplementing Regulation (EU) 2019/4 of the European Parliament and of the Council by establishing specific maximum levels of cross-contamination of antimicrobial active substances in non-target feed and methods of analysis for these substances in feed (OJ L, 2024/1229, 30.4.2024, ELI: http://data.europa.eu/eli/reg_del/2024/1229/oj).]. The scope of Implementing Regulation (EU) 2021/808 should be amended accordingly.
Recital 2, Regulation (EU) 2024/2052
In forcesince 30 Jul 2024
- num:eu=2019/4 (several documents carry this name)